onlyTrustedInfo.comonlyTrustedInfo.comonlyTrustedInfo.com
Notification
Font ResizerAa
  • News
  • Finance
  • Sports
  • Life
  • Entertainment
  • Tech
Reading: Why Investors Were Avoiding GeneDx Holdings Stock This Week
Share
onlyTrustedInfo.comonlyTrustedInfo.com
Font ResizerAa
  • News
  • Finance
  • Sports
  • Life
  • Entertainment
  • Tech
Search
  • News
  • Finance
  • Sports
  • Life
  • Entertainment
  • Tech
  • Advertise
  • Advertise
© 2025 OnlyTrustedInfo.com . All Rights Reserved.
Finance

Why Investors Were Avoiding GeneDx Holdings Stock This Week

Last updated: May 1, 2025 8:00 pm
Oliver James
Share
4 Min Read
Why Investors Were Avoiding GeneDx Holdings Stock This Week
SHARE

With a nearly 39% stock price decline this week, according to data compiled by S&P Global Market Intelligence, GeneDx Holdings (NASDAQ: WGS) was deep in the doghouse with investors. They traded out of the stock following the company’s latest earnings release and a subsequent round of analyst price target cuts.

Contents
A victim of high expectationsThe unkindest cutsShould you invest $1,000 in GeneDx right now?

A victim of high expectations

What’s interesting about GeneDx’s tumble is that its first-quarter performance was, on the surface, rather good. The figures released Wednesday revealed the DNA testing company managed to boost its revenue by 42% on a year-over-year basis to slightly more than $87 million.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

On the bottom line, it posted non-GAAP (adjusted) net income of nearly $7.7 million ($0.27 per share) against the year-ago loss of nearly $8 million.

Image source: Getty Images.

Both numbers well exceeded the consensus analyst estimates.

The catch was that GeneDx has posted more spectacular beats on analyst estimates in the past, to the point where many market players are expecting a continued level of outperformance — and disappointed when they don’t get it.

The unkindest cuts

Adding to the generally bearish sentiment, several pundits tracking GeneDx stock trimmed their price targets on the stock.

One of the cutters was BTIG’s Mark Massaro, who now feels the company is fairly valued at $100 per share; previously his level was $115. According to reports Massaro’s modeling indicates that the company now trades at only 4 times his 2026 revenue estimate, making it attractively cheap on that basis. This is a key reason why he maintained his buy recommendation despite the price target cut.

The BTIG pundit wrote in his analysis that investors overreacted to GeneDx’s quarterly results, and I’d agree. I think this is one of the more solid businesses in the biotech world, and I don’t feel investors should bail on it if it doesn’t meet inflated growth expectations.

Should you invest $1,000 in GeneDx right now?

Before you buy stock in GeneDx, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and GeneDx wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $611,271!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $684,068!*

Now, it’s worth noting Stock Advisor’s total average return is 889% — a market-crushing outperformance compared to 162% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of April 28, 2025

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

You Might Also Like

Finally, Some Good News for Tesla Investors

Trump calls on ‘Too Late Powell’ to cut interest rates after benign inflation report—but impact of tariffs is yet to hit

At least 10 people sickened in US listeria outbreak linked to prepared foods

Why Constellation Energy Stock Popped on Tuesday

Britain to bar consumers from borrowing to buy crypto under new regime

Share This Article
Facebook X Copy Link Print
Share
Previous Article From Camp to Gilded Glamour: A look back at iconic Met Gala themes From Camp to Gilded Glamour: A look back at iconic Met Gala themes
Next Article Chilean woman with muscular dystrophy becomes face of euthanasia debate as bill stalls in Senate Chilean woman with muscular dystrophy becomes face of euthanasia debate as bill stalls in Senate

Latest News

13 States Where Seniors Pay Almost Nothing in Property Taxes and Living Costs Are Below Average
13 States Where Seniors Pay Almost Nothing in Property Taxes and Living Costs Are Below Average
Finance June 8, 2025
Apple’s WWDC: Analyst Sees AI Unveil, Siri Revamp And Alibaba Deal As Catalyst For iPhone Upgrade
Apple’s WWDC: Analyst Sees AI Unveil, Siri Revamp And Alibaba Deal As Catalyst For iPhone Upgrade
Finance June 8, 2025
Graham Stephan Reveals How He Made His First Million: ‘I Could Meet People That I Would Never Ordinarily Come Into Contact With.’
Graham Stephan Reveals How He Made His First Million: ‘I Could Meet People That I Would Never Ordinarily Come Into Contact With.’
Finance June 8, 2025
A Millennial Making  An Hour Says They Worry About Ending Up Like The Old Greeters At Walmart, Asks: ‘How Are You All Doing Financially?’
A Millennial Making $20 An Hour Says They Worry About Ending Up Like The Old Greeters At Walmart, Asks: ‘How Are You All Doing Financially?’
Finance June 8, 2025
//
  • About Us
  • Contact US
  • Privacy Policy
onlyTrustedInfo.comonlyTrustedInfo.com
© 2025 OnlyTrustedInfo.com . All Rights Reserved.